2024 American Academy of Neurology Abstract Website

Disclosures for "Preclinical Development of a T Cell Receptor-engineered Regulatory T Cell Therapy for Progressive MS"

Dr. Drijvers has received personal compensation for serving as an employee of Abata Therapeutics. Dr. Drijvers has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Third Rock Ventures. Dr. Drijvers has stock in Abata Therapeutics. Dr. Drijvers has received intellectual property interests from a discovery or technology relating to health care.
Dr. Moodley has received personal compensation for serving as an employee of Abata Tx. Dr. Moodley has stock in Abata Tx. Dr. Moodley has received intellectual property interests from a discovery or technology relating to health care.
Dr. Abbadi has nothing to disclose.
Mr. Antipov has nothing to disclose.
Dr. Barrios has received personal compensation for serving as an employee of Abata Therapeutics.
Dr. Burns has received personal compensation for serving as an employee of Abata Therapeutics. Dr. Burns has received personal compensation for serving as an employee of Laronde . Dr. Burns has stock in Abata Therapeutics.
Miss Callow has received personal compensation for serving as an employee of Abata Therapeutics.
Ms. Chilton has nothing to disclose.
Mr. Feng has nothing to disclose.
Dr. Fleury has received personal compensation for serving as an employee of Abata Theraptics. Dr. Fleury has received personal compensation for serving as an employee of TCR2 Theraputics. An immediate family member of Dr. Fleury has received personal compensation for serving as an employee of Bristol Meyers Squibb. Dr. Fleury has stock in TCR2 . An immediate family member of Dr. Fleury has stock in Bristol Myers Squibb. Dr. Fleury has received intellectual property interests from a discovery or technology relating to health care.
Mr. Herrera has nothing to disclose.
Ms. Ives has received personal compensation for serving as an employee of Abata Therapeutics.
Dr. John has received personal compensation for serving as an employee of Abata Therapeutics. Dr. John has received personal compensation for serving as an employee of Ring Therapeutics. An immediate family member of Dr. John has received personal compensation for serving as an employee of Gingko Bioworks. Dr. John has stock in Abata Therapeutics. An immediate family member of Dr. John has stock in Gingko Bioworks. Dr. John has received intellectual property interests from a discovery or technology relating to health care.
Mr. Kisubika has received personal compensation for serving as an employee of Abata Therapeutics.
Mr. Lengieza has received personal compensation for serving as an employee of Abata Therapeutics. Mr. Lengieza has stock in Cellarity Inc.
Dr. Mylvaganam has nothing to disclose.
Mr. O'Malley has received personal compensation for serving as an employee of Abata Therapeutics. Mr. O'Malley has received personal compensation for serving as an employee of Camp4 Therapeutics.
Ms. Murphy has received personal compensation for serving as an employee of Abata Therapeutics.
Mr. Nelson has received personal compensation for serving as an employee of Abata Therapeutics. Mr. Nelson has stock in Abata Therapeutics.
Miss Pizzo has received personal compensation for serving as an employee of Abata Therapeutics . An immediate family member of Miss Pizzo has received personal compensation for serving as an employee of Waltham Police Department .
Dr. Schweitzer has received personal compensation for serving as an employee of Abata Therapeutics. Dr. Schweitzer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Third Rock Ventures.
Ms. Strange has received personal compensation for serving as an employee of Abata Therapeutics. Ms. Strange has received personal compensation for serving as an employee of BioNtech. Ms. Strange has stock in Abata Therapeutics. Ms. Strange has stock in Adaptimmune Therapeutics. Ms. Strange has stock in Gilead.
Miss Voorhees has received personal compensation for serving as an employee of Abata Therapeutics. Miss Voorhees has stock in Abata Therapeutics.
Miss Wang has received personal compensation for serving as an employee of Abata Therapeutics. An immediate family member of Miss Wang has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Beifang Furui. Miss Wang has received personal compensation in the range of $10,000-$49,999 for serving as a ORISE Fellow with U.S. Food and Drug Administration.
Ms. Woodall has received personal compensation for serving as an employee of Abata Therapeutics. Ms. Woodall has received personal compensation for serving as an employee of KSQ Therapeutics.
Ms. Xia has nothing to disclose.
Dr. Zhang has received personal compensation for serving as an employee of Abata Therapeutics, Inc.. Dr. Zhang has stock in Abata Therapeutics, Inc..
Richard Zhou has received personal compensation for serving as an employee of Abata Therapeutics.
Mr. Zhu has received personal compensation for serving as an employee of AbataTx. Mr. Zhu has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for ThirdRock Venture.
Dr. Nagarajan has received personal compensation for serving as an employee of Abata Therapeutics. Dr. Nagarajan has received personal compensation for serving as an employee of Inzen Therapeutics. Dr. Nagarajan has received intellectual property interests from a discovery or technology relating to health care.
Mr. Sofen has received personal compensation for serving as an employee of Abata Therapeutics. Mr. Sofen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avidity Bio. Mr. Sofen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Curie Bio. Mr. Sofen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Manta Medicines.
Dr. Van Elsas has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Van Elsas has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Mendus AB. Dr. Van Elsas has stock in Abata Therapeutics. Dr. Van Elsas has stock in Aduro Biotech, Inc.. Dr. Van Elsas has received intellectual property interests from a discovery or technology relating to health care.
Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.
Ms. Cahir-McFarland has received personal compensation for serving as an employee of Abata Therapeutics. Ms. Cahir-McFarland has received personal compensation for serving as an employee of Annexon Biosciences. Ms. Cahir-McFarland has stock in Annexon Biosciences.